Clinical Trials Browser

Recruiting × Small Bowel Adenocarcinoma × 90 days × Clear all

NCT06835387 2026-02-17

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Phase 2 Recruiting

Gastrointestinal

Small Bowel Adenocarcinoma